Finance

Lists
Q3 2026 earnings • released • EPS miss -6,24% • Revenue miss -2,98%
See results
XRAY:NASDAQ
DENTSPLY SIRONA Inc
9,46 $
-6,24%
(-0,63) 1D
9,45 $
-0,11% (-0,010)
After hours
Closed: 6 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XRAY...
Open
8,42 $
High
9,72 $
Low
8,14 $
Mkt. cap
1,89 մլրդ
Avg. vol.
4,85 մլն
Volume
10,28 մլն
52-wk high
14,76 $
52-wk low
8,14 $
EPS
-2,74 $
Beta
0,87
Shares outstanding
199,35 մլն
No. of employees
14 հզր
Open
8,42 $
High
9,72 $
Low
8,14 $
Mkt. cap
1,89 մլրդ
Avg. vol.
4,85 մլն
Volume
10,28 մլն
52-wk high
14,76 $
52-wk low
8,14 $
EPS
-2,74 $
Beta
0,87
Shares outstanding
199,35 մլն
No. of employees
14 հզր
News stories
From web sources and news partners
Profile
Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million. As an equipment maker, it designs and manufactures laboratory and specialty products relating to dental supplies. With regard to consumable products, it specializes in anesthetics, plaque and gum disease prevention and tooth polishers. It also designs and constructs artificial teeth. It has also been cited as a key player in the future intra-oral flat panel sensor market. Because of the income disparity between wealthy and developing nations, the variety of products in demand differs from region to region. On August 28, 2022, Dentsply Sirona announced the appointment of Simon D. Campion, formerly Executive Vice President and President of the Interventional segment for BD, as President and Chief Executive Officer and a member of the board. In 2018 a Netherlands-based certification company awarded Dentsply the “Top Employer” certification. Wikipedia
About DENTSPLY SIRONA Inc
CEODaniel T. Scavilla
Employees14 հզր
Founded2016
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 11 analysts giving stock ratings to XRAY in the past 3 months
Hold
Buy
2
Hold
8
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for XRAY in the last 3 months.
Highest
Current 9,46 $
14,00 $ (+47,99%)
Average
11,00 $ (+16,28%)
Lowest
9,00 $ (-4,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Sarcone
Jefferies
Hold
Maintained
10,00 $
+5,7%
11/06/2026
Lilia-Celine (Lily) Lozada
J.P. Morgan
Hold
Maintained
10,00 $
+5,7%
11/06/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
14,00 $
+48%
11/06/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
11,00 $
+16,3%
11/06/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
11,00 $
+16,3%
11/06/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
9,00 $
-4,9%
11/06/2026
Glen Santangelo
Barclays
Sell
Maintained
11,00 $
+16,3%
11/06/2026
Michael Petusky
Barrington
Buy
Maintained
13,00 $
+37,4%
10/26/2026
Michael Cherny
Leerink Partners
Hold
Maintained
10,00 $
+5,7%
10/14/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
12,00 $
+26,8%
10/09/2026
Vik Chopra
BMO Capital
Hold
Reiterated
10,00 $
+5,7%
09/16/2026
Jonathan Block
Stifel Nicolaus
Hold
Maintained
14,00 $
+48%
08/07/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
14,00 $
+48%
08/07/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
08/07/2026
David Saxon
Needham
Hold
Maintained
-
-
08/07/2026
Unknown Analyst
BMO Capital
Hold
Initiated
12,00 $
+26,8%
07/09/2026
Kevin Caliendo
UBS
Buy
Maintained
17,00 $
+79,7%
05/07/2026
Daniel Grosslight
Citi
Sell
Maintained
10,50 $
+11%
05/06/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
13,00 $
+37,4%
02/27/2026
Last report
05 նոյ, 2026 թ.
Fiscal period
Q3 2026
0,29 $ / 0,31 $
-6,24%miss
Revenue / Est. (USD)
836,00 մլն / 861,65 մլն
-2,98%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
904,00 մլն
961,00 մլն
880,00 մլն
898,00 մլն
Cost of goods sold
463,00 մլն
518,00 մլն
453,00 մլն
405,00 մլն
Cost of revenue
463,00 մլն
518,00 մլն
453,00 մլն
405,00 մլն
Research and development expenses
37,00 մլն
40,00 մլն
44,00 մլն
45,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
358,00 մլն
386,00 մլն
353,00 մլն
365,00 մլն
Operating expense
395,00 մլն
426,00 մլն
397,00 մլն
410,00 մլն
Total operating expenses
858,00 մլն
944,00 մլն
850,00 մլն
815,00 մլն
Operating income
46,00 մլն
17,00 մլն
30,00 մլն
83,00 մլն
Other non operating income
1,00 մլն
-2,00 մլն
6,00 մլն
-
EBT including unusual items
-230,00 մլն
-147,00 մլն
-42,00 մլն
72,00 մլն
EBT excluding unusual items
37,00 մլն
12,00 մլն
25,00 մլն
74,00 մլն
Income tax expense
198,00 մլն
-2,00 մլն
-32,00 մլն
36,00 մլն
Effective tax rate
-86,09%
1,36%
76,19%
50,00%
Other operating expenses
-
-
-
-
Net income
-427,00 մլն
-146,00 մլն
-10,00 մլն
37,00 մլն
Net profit margin
-47,23%
-15,19%
-1,14%
4,12%
Earnings per share
0,37
0,27
0,27
0,52
Interest and investment income
3,00 մլն
4,00 մլն
-
4,00 մլն
Interest expense
-26,00 մլն
-26,00 մլն
-24,00 մլն
-26,00 մլն
Net interest expenses
-23,00 մլն
-22,00 մլն
-24,00 մլն
-22,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
138,00 մլն
110,00 մլն
109,00 մլն
168,00 մլն
Gain or loss from assets sale
-
-
-6,00 մլն
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps